Arvee Laboratories (India) Limited is a specialized chemical manufacturing entity headquartered in **Ahmedabad, Gujarat**, with a dedicated production facility in **Bhavnagar**. The company is a key player in the Indian specialty chemicals landscape, leveraging India’s status as the **6th largest** chemical producer globally and the **2nd largest** manufacturer and exporter of dyes. Arvee operates as a standalone entity with **no subsidiaries, joint ventures, or associates**, ensuring a streamlined corporate structure focused on high-growth chemical applications. --- ### Manufacturing Infrastructure and Operational Footprint The company’s industrial operations are centralized at its manufacturing plant located at **Survey No. 316, Bhavnagar Shihor Road, Post: Vartej, Kardej, Dist. Bhavnagar, Gujarat**. * **Workforce:** As of **March 31, 2024**, the company maintains a specialized workforce of **65 personnel**. * **Compliance & Audit:** The company adheres to the Companies Act, 2013, regarding cost records. Due to an annual turnover exceeding **Rs. 50 Crores**, the company transitioned into the **Cost Audit** regime effective from the **FY 2024-25** period. * **Quality Control:** Operations are supported by strict safety and quality control programs designed to meet international standards, essential for its export-oriented business model. --- ### Strategic Business Segmentation As of **December 2025**, management has refined its reporting to distinguish between two primary application areas within its core **Chemicals** segment. This allows for targeted capital allocation and market-specific strategies. #### 1. Textile Segment Focuses on the production of chemicals used in the processing and finishing of textiles, capitalizing on India’s massive domestic textile industry and global export demand for dyes and pigments. #### 2. Non-Textile Segment This segment encompasses a diverse range of high-growth industrial applications: * **Specialty Chemicals:** Serving high-tech sectors including **Electronics, Automotive, and Construction**. This is identified as the company's **strongest pillar**, driven by global industrial decarbonization. * **Inorganic Chemicals:** Core chemicals for foundational manufacturing and domestic infrastructure. * **Petrochemicals:** Large-scale derivatives integrated into global supply chains. | Segment | Key Demand Drivers | Primary Export Destinations | | :--- | :--- | :--- | | **Specialty Chemicals** | Decarbonization, Sustainability, Electronics | **USA, China, Brazil** | | **Inorganic Chemicals** | Industrial manufacturing, Infrastructure | **Netherlands, Saudi Arabia** | | **Petrochemicals** | Scalable business models, Global supply chains | Global Markets | --- ### Financial Performance and Capital Structure Arvee Laboratories is listed on the **NSE Main Board**. The company demonstrated a robust financial recovery in the fiscal year ended **March 31, 2025**, characterized by a triple-digit surge in net profitability. #### FY 2024-25 Financial Highlights (Standalone) | Particulars | FY 2024-25 (₹ in Thousands) | FY 2023-24 (₹ in Thousands) | % Change | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **3,84,872.01** | **3,03,451.69** | **+26.83%** | | **Total Revenue** | **3,91,440.81** | **3,09,851.23** | **+26.33%** | | **Profit Before Tax (PBT)** | **28,708.40** | **18,295.12** | **+56.92%** | | **Profit After Tax (PAT)** | **21,473.10** | **10,518.35** | **+104.15%** | | **Paid-up Equity Capital** | **11,020.00** | **11,020.00** | **-** | #### Shareholding Pattern (as of March 31, 2024) The shareholding is **100% dematerialized**, reflecting high transparency and liquidity for investors. * **Total Issued Capital:** **11,020,000 shares** (Face Value **Rs. 10**). * **Other Equity:** **Rs. 1,809.40 Lakhs**. * **CDSL Holding:** **98.99%** | **NSDL Holding:** **1.01%**. --- ### Debt Management and Liquidity The company maintains a balanced liquidity profile through a combination of institutional credit and promoter support: * **Export Packing Credit:** Sourced from **Standard Chartered Bank** at **LIBOR + 200 BPs** (90-day tenure). * **Working Capital Facility:** Sourced from **Standard Chartered Bank** at **3.77% + 3-month MIBOR**. * **Unsecured Loans:** Provided by **Directors and relatives** at interest rates of **12% to 15%** per annum, providing flexible on-demand liquidity. * **Gearing Ratio:** The company aligns with the industry standard of maintaining a **gearing ratio below 0.5x**, ensuring a healthy balance sheet. --- ### Growth Strategy: The "China+1" Opportunity Arvee Laboratories is positioning itself to capture the shift in global supply chains away from China and Europe (due to high energy costs). The strategy is built on three pillars: 1. **Capacity Augmentation:** Leveraging industry-wide trends where specialty chemical capex reached **₹22,000 crore** in FY23-24. 2. **Market Expansion:** Utilizing a **direct market route** for large-scale customers and building a dedicated sales force to penetrate new geographical locations. 3. **Value Chain Migration:** Shifting from basic chemicals to **high-value downstream products** and crude-to-chemicals complexes to ensure structural resilience. #### Sector Growth Projections (2021–2027) * **Specialty Chemicals:** **11.5% CAGR** * **Agrochemicals:** **8.3% CAGR** * **Petrochemicals:** **11% CAGR** * **Long-term Target:** The Indian chemical market is projected to reach **$1 Trillion by 2040**. --- ### Risk Mitigation and Governance Framework The company operates under a formal **Risk Management Framework** reviewed annually by the **Audit Committee**. * **Operational Risks:** Mitigated through investment in **Information Technology** security and **Occupational Safety** protocols. * **Human Capital Risk:** High dependency on **Promoters and KMPs** is addressed through talent retention strategies. * **Market Volatility:** To counter "Chinese dumping" and inventory losses, the company focuses on **domestic demand** (projected **8-9% growth**), which currently accounts for **60%** of industry revenue. * **Macro-Environmental Risks:** The company proactively monitors **global warming** and **regulatory changes** in India, utilizing outside professional help to align mitigation with its **risk appetite**. * **Government Alignment:** The company seeks to benefit from the **PCPIR Policy** (aiming for **₹20 Lakh Crore** investment by 2035) and proposed **PLI Schemes** for chemicals and agrochemicals.